Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sargassum polycystum extract is derived from the brown seaweed Sargassum polycystum, a marine macroalga commonly found in tropical coastal regions. The extract contains a variety of bioactive compounds, notably polyphenols, sulfated polysaccharides, saponins, flavonoids, tannins, terpenoids, steroids, and glycosides[3][8]. It has been investigated for several pharmacological activities, including **anti-stress**, **antioxidant**, **anti-inflammatory**, **hepatoprotective**, **anticancer**, **antimicrobial**, and **antihyperglycemic** effects[1][3][4][5][7]. Mechanistically, the extract’s bioactivity has been linked to its antioxidant polyphenols, suppression of lipid peroxidation, restoration of hepatic antioxidant defenses, and inhibition of key metabolic enzymes such as α-glucosidase[1][3][4][7]. It is used in traditional medicine as a functional food or supplement and is under study for possible nutraceutical and pharmaceutical applications[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sargassum polycystum extract.